Celldex Therapeutics (CLDX) Leases (2019 - 2025)
Historic Leases for Celldex Therapeutics (CLDX) over the last 7 years, with Q3 2025 value amounting to $2.7 million.
- Celldex Therapeutics' Leases fell 1429.02% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year decrease of 1429.02%. This contributed to the annual value of $3.9 million for FY2024, which is 5126.12% up from last year.
- As of Q3 2025, Celldex Therapeutics' Leases stood at $2.7 million, which was down 1429.02% from $3.1 million recorded in Q2 2025.
- Celldex Therapeutics' Leases' 5-year high stood at $4.0 million during Q4 2022, with a 5-year trough of $2.2 million in Q1 2024.
- Moreover, its 5-year median value for Leases was $3.1 million (2021), whereas its average is $3.1 million.
- Per our database at Business Quant, Celldex Therapeutics' Leases tumbled by 4040.74% in 2024 and then surged by 6230.95% in 2025.
- Quarter analysis of 5 years shows Celldex Therapeutics' Leases stood at $3.0 million in 2021, then surged by 34.71% to $4.0 million in 2022, then crashed by 35.59% to $2.6 million in 2023, then soared by 51.26% to $3.9 million in 2024, then plummeted by 30.3% to $2.7 million in 2025.
- Its Leases was $2.7 million in Q3 2025, compared to $3.1 million in Q2 2025 and $3.5 million in Q1 2025.